Home » Stocks » PRA Health Sciences

PRA Health Sciences, Inc. (PRAH)

Stock Price: $105.66 USD -2.99 (-2.75%)
Updated Aug 7, 2020 12:02 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 6.72B
Revenue (ttm) 3.13B
Net Income (ttm) 239.60M
Shares Out 63.72M
EPS (ttm) 3.66
PE Ratio 28.87
Forward PE 26.11
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $105.66
Previous Close $108.65
Change ($) -2.99
Change (%) -2.75%
Day's Open 106.37
Day's Range 102.80 - 109.52
Day's Volume 385,935
52-Week Range 58.67 - 113.32

More Stats

Market Cap 6.72B
Enterprise Value 8.07B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 63.72M
Float 63.53M
EPS (basic) 3.75
EPS (diluted) 3.66
FCF / Share 3.14
Dividend n/a
Dividend Yield n/a
Earnings Yield 3.46%
FCF Yield 2.94%
Payout Ratio n/a
Shares Short 1.42M
Short Ratio 3.28
Short % of Float 2.67%
Beta 1.10
PE Ratio 28.87
Forward PE 26.11
P/FCF Ratio 34.07
PS Ratio 2.15
PB Ratio 6.21
Revenue 3.13B
Operating Income 348.64M
Net Income 239.60M
Free Cash Flow 197.32M
Net Cash -1.35B
Net Cash / Share -21.23
Gross Margin 48.81%
Operating Margin 11.15%
Profit Margin 7.70%
FCF Margin 6.31%
ROA 6.18%
ROE 21.55%
ROIC 20.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (14)

Buy 5
Overweight 1
Hold 8
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$106.77*
(1.05% upside)
Low
90.0
Current: $105.66
High
128.0
Target: 106.77
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue3,0662,8722,2591,8121,6141,460
Revenue Growth6.77%27.11%24.71%12.26%10.57%-
Gross Profit877801665547489407
Operating Income36428117616316354.59
Net Income24315486.9368.1881.77-35.74
Shares Outstanding64.5164.1262.4460.7659.9742.90
Earnings Per Share3.682.321.321.061.29-0.83
EPS Growth58.62%75.76%24.53%-17.83%--
Operating Cash Flow25433022016015234.03
Capital Expenditures-74.27-55.84-61.26-33.13-32.77-27.32
Free Cash Flow1792741591271206.71
Cash & Equivalents23614519314912691.53
Total Debt1,4641,0821,346828890924
Net Cash / Debt-1,228-938-1,153-679-763-833
Assets3,5443,1863,3582,1902,2292,214
Liabilities2,4542,1352,4221,4611,5261,538
Book Value1,0901,045931729703677
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PRA Health Sciences, Inc.
Country United States
Employees 17,500
CEO Colin Shannon

Stock Information

Ticker Symbol PRAH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PRAH
IPO Date November 13, 2014

Description

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.